Pat Soon-Shiong: Expanding Access to Hard-to-Treat Cancers Through CSSIFM Trials
Aug 31, 2025, 07:05

Pat Soon-Shiong: Expanding Access to Hard-to-Treat Cancers Through CSSIFM Trials

Pat Soon-Shiong, Chairman of Chan Soon-Shiong Family Foundation, Executive Chairman at ImmunityBio, Executive Chairman of Los Angeles Times, shared a post on X:

“In order to provide us much access as possible we have opened randomized trials CSSIFM for the following cancers: non small cell lung cancer in which patients have failed chemo and checkpoint inhibitors / glioblastoma failed surgery, radiation and temodor. Soon advanced colon cancer, papillary bladder cancer failed BCG and HPV positive cancers.”

More posts featuring Pat Soon-Shiong.